- Home
- AARD vs BZUN Comparison
AARD vs BZUN Comparison
Compare AARD & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- BZUN
- Stock Information
- Founded
- AARD 2017
- BZUN 2007
- Country
- AARD United States
- BZUN China
- Employees
- AARD N/A
- BZUN N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- BZUN Catalog/Specialty Distribution
- Sector
- AARD Health Care
- BZUN Consumer Discretionary
- Exchange
- AARD Nasdaq
- BZUN Nasdaq
- Market Cap
- AARD 154.9M
- BZUN 131.2M
- IPO Year
- AARD 2025
- BZUN N/A
- Fundamental
- Price
- AARD $7.04
- BZUN $2.28
- Analyst Decision
- AARD Strong Buy
- BZUN Buy
- Analyst Count
- AARD 4
- BZUN 2
- Target Price
- AARD $31.50
- BZUN $3.20
- AVG Volume (30 Days)
- AARD 129.3K
- BZUN 398.9K
- Earning Date
- AARD 01-01-0001
- BZUN 05-27-2025
- Dividend Yield
- AARD N/A
- BZUN N/A
- EPS Growth
- AARD N/A
- BZUN N/A
- EPS
- AARD N/A
- BZUN N/A
- Revenue
- AARD N/A
- BZUN $1,290,875,449.00
- Revenue This Year
- AARD N/A
- BZUN $5.14
- Revenue Next Year
- AARD N/A
- BZUN $4.04
- P/E Ratio
- AARD N/A
- BZUN N/A
- Revenue Growth
- AARD N/A
- BZUN 6.92
- 52 Week Low
- AARD $4.88
- BZUN $2.11
- 52 Week High
- AARD $19.58
- BZUN $4.38
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- BZUN 27.19
- Support Level
- AARD N/A
- BZUN $2.14
- Resistance Level
- AARD N/A
- BZUN $2.44
- Average True Range (ATR)
- AARD 0.00
- BZUN 0.16
- MACD
- AARD 0.00
- BZUN -0.01
- Stochastic Oscillator
- AARD 0.00
- BZUN 11.85
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).